GlassScriptPhysician profile
Jason Brancato
NPI 1407000854
$10,106.53
in general payments reported to CMS, 2019-2025
54 companies · $2,626 in 2025
The $2,626 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,904 · 2022: $2,003 · 2023: $1,428 · 2024: $2,146 · 2025: $2,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,035 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,034.91 |
| Education | $164.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,529.09 | 2021-2025 | |
| Amgen INC. | $1,129.80 | 2021-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,033.23 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,007.53 | 2021-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $850.96 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $527.99 | 2021-2025 | Jardiance, Synjardy |
| Pfizer INC. | $476.23 | 2021-2025 | |
| Novo Nordisk INC | $384.53 | 2021-2025 | Wegovy, Saxenda, Rybelsus |
| Dermavant Sciences, INC. | $223.55 | 2023-2024 | Vtama |
| Bayer Healthcare Pharmaceuticals INC. | $185.70 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $184.27 | 2021-2022 | |
| Lundbeck LLC | $177.67 | 2024-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $164.98 | 2023-2025 | |
| Intra-Sana Laboratories | $144.99 | 2023-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Axsome Therapeutics, INC. | $122.98 | 2025 | Symbravo |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Brancato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.